McElhaugh Michael J. 4
4 · Arbutus Biopharma Corp · Filed Jan 20, 2022
Insider Transaction Report
Form 4
McElhaugh Michael J.
DirectorInterim President & CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-01-20$2.81/sh+325,850$915,639→ 325,850 totalExercise: $2.81Exp: 2032-01-20→ Common Shares (325,850 underlying)
Footnotes (1)
- [F1]These stock options will vest and become exercisable 1/48th each month over the four year period.